Abstract
Spondyloarthritis (SpA) are chronic inflammatory rheumatic diseases with wide spectrum of clinical manifestations. In treatment are presently avaible higly effective drug thank to more detailed understanding of disease.
Drug areeffective in treatmnet of inflammation manifestations and slow progresion of the diseases.